Targeting of NSCLC in 2011

2 Visninger
administrator
administrator
07/30/23

Targeting of NSCLC in 2011

  • Kategori

Vis mere
0 Kommentarer Sorter efter

    Ingen kommentarer fundet

    Facebook kommentarer

    Nรฆste

    Targeting ฮฒ-amyloid and tau in Alzheimer's disease
    00:03:11
    Targeting ฮฒ-amyloid and tau in Alzheimer's disease
    administrator
    2 Visninger
    Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
    00:02:30
    Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
    administrator
    4 Visninger
    Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
    01:15:45
    Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
    administrator
    3 Visninger
    Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
    00:11:42
    Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
    administrator
    4 Visninger
    DTRF @ BMAD 2011
    00:02:03
    DTRF @ BMAD 2011
    administrator
    2 Visninger
    Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
    00:05:45
    Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
    administrator
    4 Visninger
    STEAP1 targeting CAR-T therapy for solid tumors
    00:02:17
    STEAP1 targeting CAR-T therapy for solid tumors
    administrator
    0 Visninger
    STEAP1 targeting CAR-T therapy for solid tumors
    00:02:17
    STEAP1 targeting CAR-T therapy for solid tumors
    administrator
    2 Visninger
    Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
    00:29:54
    Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
    administrator
    1 Visninger
    Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
    00:29:29
    Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
    administrator
    1 Visninger
    2020 Targeting ALK - From Discovery to Frontline Treatment
    00:45:52
    2020 Targeting ALK - From Discovery to Frontline Treatment
    administrator
    5 Visninger
    Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
    00:39:36
    Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
    administrator
    4 Visninger
    Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
    00:01:10
    Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
    administrator
    2 Visninger
    Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
    00:59:21
    Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
    administrator
    3 Visninger
    Melanoma 2011 and Beyond
    00:28:00
    Melanoma 2011 and Beyond
    administrator
    11 Visninger
    Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
    00:01:23
    Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
    administrator
    5 Visninger
    Targeting chronic inflammation in MPNs
    00:02:26
    Targeting chronic inflammation in MPNs
    administrator
    3 Visninger
    FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
    00:06:58
    FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
    administrator
    1 Visninger
    Unresectable NSCLC - Tumor Mutational Burden (TMB), the Value in Testing
    00:06:23
    Unresectable NSCLC - Tumor Mutational Burden (TMB), the Value in Testing
    administrator
    1 Visninger